- Home
- ELEV vs INLF Comparison
ELEV vs INLF Comparison
Compare ELEV & INLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- INLF
- Stock Information
- Founded
- ELEV 2019
- INLF 2016
- Country
- ELEV United States
- INLF China
- Employees
- ELEV N/A
- INLF N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- INLF Industrial Machinery/Components
- Sector
- ELEV Health Care
- INLF Industrials
- Exchange
- ELEV Nasdaq
- INLF Nasdaq
- Market Cap
- ELEV 20.0M
- INLF 18.1M
- IPO Year
- ELEV 2021
- INLF 2025
- Fundamental
- Price
- ELEV $0.34
- INLF $1.27
- Analyst Decision
- ELEV Buy
- INLF
- Analyst Count
- ELEV 6
- INLF 0
- Target Price
- ELEV $2.94
- INLF N/A
- AVG Volume (30 Days)
- ELEV 975.2K
- INLF 43.3K
- Earning Date
- ELEV 05-23-2025
- INLF 01-01-0001
- Dividend Yield
- ELEV N/A
- INLF N/A
- EPS Growth
- ELEV N/A
- INLF 18.78
- EPS
- ELEV N/A
- INLF 0.13
- Revenue
- ELEV N/A
- INLF $15,796,983.00
- Revenue This Year
- ELEV N/A
- INLF N/A
- Revenue Next Year
- ELEV N/A
- INLF N/A
- P/E Ratio
- ELEV N/A
- INLF $10.66
- Revenue Growth
- ELEV N/A
- INLF 25.27
- 52 Week Low
- ELEV $0.22
- INLF $1.15
- 52 Week High
- ELEV $4.33
- INLF $21.00
- Technical
- Relative Strength Index (RSI)
- ELEV 48.18
- INLF N/A
- Support Level
- ELEV $0.33
- INLF N/A
- Resistance Level
- ELEV $0.37
- INLF N/A
- Average True Range (ATR)
- ELEV 0.03
- INLF 0.00
- MACD
- ELEV 0.00
- INLF 0.00
- Stochastic Oscillator
- ELEV 25.54
- INLF 0.00
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.
About INLF INLIF LIMITED Ordinary Shares
INLIF Ltd is a holding company and does business through its subsidiary. It is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms also a provider of installation services and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.